232 related articles for article (PubMed ID: 1349015)
1. Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses.
Spivak-Kroizman T; Rotin D; Pinchasi D; Ullrich A; Schlessinger J; Lax I
J Biol Chem; 1992 Apr; 267(12):8056-63. PubMed ID: 1349015
[TBL] [Abstract][Full Text] [Related]
2. Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.
Qian X; LeVea CM; Freeman JK; Dougall WC; Greene MI
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1500-4. PubMed ID: 7509075
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
4. Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members.
Fedi P; Pierce JH; di Fiore PP; Kraus MH
Mol Cell Biol; 1994 Jan; 14(1):492-500. PubMed ID: 8264617
[TBL] [Abstract][Full Text] [Related]
5. Evidence that autophosphorylation of solubilized receptors for epidermal growth factor is mediated by intermolecular cross-phosphorylation.
Honegger AM; Kris RM; Ullrich A; Schlessinger J
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):925-9. PubMed ID: 2915986
[TBL] [Abstract][Full Text] [Related]
6. The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency.
Fazioli F; Kim UH; Rhee SG; Molloy CJ; Segatto O; Di Fiore PP
Mol Cell Biol; 1991 Apr; 11(4):2040-8. PubMed ID: 1672440
[TBL] [Abstract][Full Text] [Related]
7. An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors.
Wright JD; Reuter CW; Weber MJ
J Biol Chem; 1995 May; 270(20):12085-93. PubMed ID: 7538132
[TBL] [Abstract][Full Text] [Related]
8. Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation.
Qian X; Dougall WC; Hellman ME; Greene MI
Oncogene; 1994 May; 9(5):1507-14. PubMed ID: 7908733
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity.
Gotoh N; Tojo A; Muroya K; Hashimoto Y; Hattori S; Nakamura S; Takenawa T; Yazaki Y; Shibuya M
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):167-71. PubMed ID: 7506413
[TBL] [Abstract][Full Text] [Related]
10. Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells.
Honegger AM; Schmidt A; Ullrich A; Schlessinger J
Mol Cell Biol; 1990 Aug; 10(8):4035-44. PubMed ID: 2164634
[TBL] [Abstract][Full Text] [Related]
11. p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases.
Quian XL; Decker SJ; Greene MI
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1330-4. PubMed ID: 1346931
[TBL] [Abstract][Full Text] [Related]
12. Effects of substitution of threonine 654 of the epidermal growth factor receptor on epidermal growth factor-mediated activation of phospholipase C.
Decker SJ; Ellis C; Pawson T; Velu T
J Biol Chem; 1990 Apr; 265(12):7009-15. PubMed ID: 2108964
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.
Deb TB; Su L; Wong L; Bonvini E; Wells A; David M; Johnson GR
J Biol Chem; 2001 May; 276(18):15554-60. PubMed ID: 11279155
[TBL] [Abstract][Full Text] [Related]
15. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization.
Kashles O; Yarden Y; Fischer R; Ullrich A; Schlessinger J
Mol Cell Biol; 1991 Mar; 11(3):1454-63. PubMed ID: 1705006
[TBL] [Abstract][Full Text] [Related]
16. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites.
Decker SJ
J Biol Chem; 1993 May; 268(13):9176-9. PubMed ID: 8387484
[TBL] [Abstract][Full Text] [Related]
18. Multiple autophosphorylation sites of the epidermal growth factor receptor are essential for receptor kinase activity and internalization. Contrasting significance of tyrosine 992 in the native and truncated receptors.
Sorkin A; Helin K; Waters CM; Carpenter G; Beguinot L
J Biol Chem; 1992 Apr; 267(12):8672-8. PubMed ID: 1314835
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor (EGF)-stimulated tyrosine phosphorylation and EGF receptor degradation in cells expressing EGF receptors truncated at residue 973.
Decker SJ; Alexander C; Habib T
J Biol Chem; 1992 Jan; 267(2):1104-8. PubMed ID: 1730638
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor.
Chen X; Resh MD
J Biol Chem; 2002 Dec; 277(51):49631-7. PubMed ID: 12397069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
